AzurRx BioPharma acquires US biotech company First Wave Bio for $229m
AzurRx BioPharma has signed a stock and cash deal worth $229 million to acquire Florida-based clinical-stage biotech company First Wave Bio. The consideration includes payments for certain development, regulatory and sales milestones. First Wave Bio specializes in developing gut-targeted, small molecule therapies for auto-immune inflammatory bowel diseases (IBD) and other serious disorders. The buyer – […]